|
48
|
168
|
4ja1A |
Structure of mmp3 complexed with a platinum-based inhibitor |
|
46
|
169
|
4jp4A |
Mmp13 in complex with a reverse hydroxamate zn-binder |
|
47
|
169
|
4jpaA |
Mmp13 in complex with a piperazine hydantoin ligand |
|
46
|
159
|
4i03A |
Human mmp12 in complex with a peg-linked bifunctional l-glutamate motif inhibitor |
|
38
|
160
|
4h82A |
Crystal structure of mutant mmp-9 catalytic domain in complex with a twin inhibitor. |
|
38
|
164
|
4h2eA |
Crystal structure of an mmp twin inhibitor complexing two mmp-9 catalytic domains |
|
49
|
159
|
4h49A |
Crystal structure of the catalytic domain of mmp-12 in complex with a twin inhibitor. |
|
51
|
159
|
4h30A |
Crystal structure of the catalytic domain of mmp-12 in complex with a twin inhibitor. |
|
47
|
164
|
4h3xA |
Crystal structure of an mmp broad spectrum hydroxamate based inhibitor cc27 in complex with the mmp-9 catalytic domain |
|
48
|
159
|
4h84A |
Crystal structure of the catalytic domain of human mmp12 in complex with a selective carboxylate based inhibitor. |
|
41
|
160
|
4hmaA |
Crystal structure of an mmp twin carboxylate based inhibitor lc20 in complex with the mmp-9 catalytic domain |
|
46
|
159
|
4h76A |
Crystal structure of the catalytic domain of human mmp12 in complex with a broad spectrum hydroxamate inhibitor |
|
43
|
158
|
4guyA |
Human mmp12 catalytic domain in complex with*n*-hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acetamide |
|
45
|
159
|
4gr3A |
Crystal structure of the catalytic domain of human mmp12 in complex with selective phosphinic inhibitor rxp470a |
|
44
|
152
|
4gr8A |
Crystal structure of the catalytic domain of human mmp12 in complex with selective phosphinic inhibitor rxp470c |
|
46
|
160
|
4h1qA |
Crystal structure of mutant mmp-9 catalytic domain in complex with a twin inhibitor. |
|
174
|
573
|
4gwmA |
Crystal structure of human promeprin beta |
|
152
|
533
|
4gwnA |
Crystal structure of human mature meprin beta |
|
45
|
159
|
4gr0A |
Crystal structure of the catalytic domain of human mmp12 in complex with selective phosphinic inhibitor rxp470b |
|
41
|
159
|
4gqlA |
Crystal structure of the catalytic domain of human mmp12 in complex with selective phosphinic inhibitor rxp470.1 |
|
49
|
168
|
4g9lA |
Structure of mmp3 complexed with nngh inhibitor. |
|
222
|
664
|
4fxyP |
Crystal structure of rat neurolysin with bound pyrazolidin inhibitor |
|
148
|
448
|
4gf1A |
Crystal structure of certhrax |
|
87
|
368
|
4g0dA |
Human collagenase 3 (mmp-13) full form with peptides from pro-domain |
|
92
|
368
|
4fvlA |
Human collagenase 3 (mmp-13) full form with peptides from pro-domain |
|
82
|
368
|
4fu4A |
Human collagenase 3 (mmp-13) with peptide from pro-domain |
|
161
|
451
|
4fxqA |
Full-length certhrax toxin from bacillus cereus in complex with inhibitor p6 |
|
91
|
296
|
3q2hA |
Adamts1 in complex with n-hydroxyformamide inhibitors of adam-ts4 |
|
92
|
296
|
3q2gA |
Adamts1 in complex with a novel n-hydroxyformamide inhibitors |
|
47
|
167
|
3ohlA |
Catalytic domain of stromelysin-1 in complex with n-hydroxy-2-(4-methoxy-n-(pyridine-3-ylmethyl)phenylsulfonamido)acetamide |
|
117
|
406
|
3p1vA |
Crystal structure of a metallo-endopeptidases (bacova_00663) from bacteroides ovatus at 1.93 a resolution |
|
45
|
167
|
3ohoA |
Catalytic domain of stromelysin-1 in complex with n-hydroxy-2-(4-methylphenylsulfonamido)acetamide |
|
120
|
365
|
3p24A |
Structure of profragilysin-3 from bacteroides fragilis |
|
82
|
258
|
3o64A |
Crystal structure of catalytic domain of tace with 2-(2-aminothiazol-4-yl)pyrrolidine-based tartrate diamides |
|
46
|
164
|
3o2xA |
Mmp-13 in complex with selective tetrazole core inhibitor |
|
43
|
158
|
3nx7A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-hydroxy-2-(n-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide |
|
44
|
158
|
3n2uA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-hydroxy-2-(4-methoxy-n(2-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)ethyl)phenylsulfonamido)acetamide |
|
43
|
158
|
3n2vA |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor n-hydroxy-2-(n-hydroxyethyl)biphenyl-4-ylsulfonamido)acetamide |
|
49
|
168
|
3ma2A |
Complex membrane type-1 matrix metalloproteinase (mt1-mmp) with tissue inhibitor of metalloproteinase-1 (timp-1) |
|
81
|
257
|
3le9A |
Crystal structure of the catalytic domain of tace with indazolinone-phenyl-hydantoin inhibitor |
|
69
|
198
|
3lqbA |
Crystal structure of the hatching enzyme zhe1 from the zebrafish danio rerio |
|
80
|
257
|
3lgpA |
Crystal structure of catalytic domain of tace with benzimidazolyl-thienyl-tartrate based inhibitor |
|
43
|
158
|
3lk8A |
Crystal structure of the catalytic domain of human mmp12 complexed with the inhibitor paramethoxy-sulfonyl-glycine hydroxamate |
|
46
|
159
|
3lilA |
Human mmp12 in complex with non-zinc chelating inhibitor |
|
44
|
159
|
3ljgA |
Human mmp12 in complex with non-zinc chelating inhibitor |
|
65
|
235
|
3lq0A |
Zymogen structure of crayfish astacin metallopeptidase |
|
44
|
159
|
3likA |
Human mmp12 in complex with non-zinc chelating inhibitor |
|
46
|
164
|
3ljzA |
Crystal structure of human mmp-13 complexed with an amino-2-indanol compound |
|
85
|
259
|
3lunA |
Structure of ulilysin mutant m290c |
|
60
|
191
|
3lmcA |
Crystal structure of zinc-dependent peptidase from methanocorpusculum labreanum (strain z), northeast structural genomics consortium target mur16 |
